HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lisa Licitra Selected Research

DNA (Deoxyribonucleic Acid)

12/2022Comparing BamHI-W and CE-marked assays to detect circulating Epstein-Barr Virus (EBV) DNA of nasopharyngeal cancer patients in a non-endemic area.
12/2022International recommendations for plasma Epstein-Barr virus DNA measurement in nasopharyngeal carcinoma in resource-constrained settings: lessons from the COVID-19 pandemic.
1/2021The appropriate use of circulating EBV-DNA in nasopharyngeal carcinoma: Comprehensive clinical practice guidelines evaluation.
5/2019Role of pretreatment 18F-FDG PET/CT parameters in predicting outcome of non-endemic EBV DNA-related nasopharyngeal cancer (NPC) patients treated with IMRT and chemotherapy.
7/2017Circulating pre-treatment Epstein-Barr virus DNA as prognostic factor in locally-advanced nasopharyngeal cancer in a non-endemic area.
4/2015Genetic profiling of advanced radioactive iodine-resistant differentiated thyroid cancer and correlation with axitinib efficacy.
12/2014Alterations associated with androgen receptor gene activation in salivary duct carcinoma of both sexes: potential therapeutic ramifications.
12/2006High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma.
11/2006Molecular and cytogenetic subgroups of oropharyngeal squamous cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lisa Licitra Research Topics

Disease

67Neoplasms (Cancer)
01/2024 - 01/2003
63Squamous Cell Carcinoma of Head and Neck
03/2024 - 11/2006
43Head and Neck Neoplasms (Head and Neck Cancer)
11/2023 - 08/2002
11Carcinoma (Carcinomatosis)
10/2022 - 01/2013
10Squamous Cell Neoplasms (Squamous Cell Cancer)
11/2023 - 01/2003
9Basal Cell Carcinoma (Rodent Ulcer)
10/2023 - 01/2015
9Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
12/2022 - 01/2004
9Neoplasm Metastasis (Metastasis)
12/2022 - 02/2003
8Nasopharyngeal Carcinoma
12/2022 - 01/2004
8Salivary Gland Neoplasms (Salivary Gland Cancer)
12/2021 - 05/2004
8Fatigue
10/2020 - 10/2013
8Disease Progression
01/2020 - 11/2016
7Thyroid Neoplasms (Thyroid Cancer)
04/2023 - 07/2008
7Oropharyngeal Neoplasms
12/2022 - 10/2012
7Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2022 - 06/2007
6Stomatitis
03/2024 - 09/2014
5Adenoid Cystic Carcinoma (Cylindroma)
12/2022 - 10/2005
5Adenocarcinoma
01/2022 - 06/2003
4Deglutition Disorders (Dysphagia)
03/2024 - 11/2015
4Pain (Aches)
01/2017 - 10/2015
4Mucositis
12/2016 - 02/2012
3Pneumonia (Pneumonitis)
03/2024 - 06/2014
3Melanoma (Melanoma, Malignant)
11/2021 - 10/2017
3Anaplastic Thyroid Carcinoma
01/2021 - 02/2014
3Exanthema (Rash)
10/2019 - 10/2013
3Diarrhea
10/2019 - 10/2013
3Neutropenia
01/2017 - 02/2014
2Sepsis (Septicemia)
03/2024 - 08/2015
2Acute Kidney Injury (Acute Renal Failure)
03/2024 - 11/2023
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 04/2013
2Hemorrhage
01/2021 - 04/2009
2Nausea
10/2019 - 10/2013
2Weight Loss (Weight Reduction)
01/2019 - 01/2017
2medullary Thyroid cancer
01/2018 - 10/2013
2Colorectal Neoplasms (Colorectal Cancer)
04/2013 - 10/2006
2Genetic Predisposition to Disease (Genetic Predisposition)
04/2006 - 07/2003
2Avitaminosis (Vitamin Deficiency)
07/2003 - 01/2002
1Chronic Kidney Failure (Chronic Renal Failure)
03/2024
1Aspiration Pneumonia
03/2024
1Febrile Neutropenia
03/2024
1Sclerosing Cholangitis
03/2024
1Sarcopenia
10/2023

Drug/Important Bio-Agent (IBA)

30PlatinumIBA
01/2024 - 10/2005
22Cetuximab (Erbitux)FDA Link
10/2023 - 10/2005
16Biomarkers (Surrogate Marker)IBA
01/2024 - 11/2006
15NivolumabIBA
01/2024 - 11/2016
14Cisplatin (Platino)FDA LinkGeneric
11/2023 - 07/2002
10Immune Checkpoint InhibitorsIBA
01/2024 - 10/2017
9DNA (Deoxyribonucleic Acid)IBA
12/2022 - 11/2006
7pembrolizumabIBA
03/2024 - 01/2019
7Fluorouracil (Carac)FDA LinkGeneric
01/2020 - 01/2004
7HhAntag691IBA
12/2018 - 01/2015
6ErbB Receptors (EGF Receptor)IBA
10/2022 - 04/2013
6Androgen Receptors (Androgen Receptor)IBA
01/2022 - 05/2004
6Methotrexate (Mexate)FDA LinkGeneric
12/2019 - 04/2009
4cemiplimabIBA
10/2023 - 01/2021
4AndrogensIBA
12/2021 - 06/2014
4MicroRNAs (MicroRNA)IBA
01/2020 - 01/2017
4Docetaxel (Taxotere)FDA Link
12/2019 - 11/2016
4Carboplatin (JM8)FDA LinkGeneric
01/2019 - 02/2014
4Paclitaxel (Taxol)FDA LinkGeneric
01/2018 - 02/2014
3IodineIBA
01/2023 - 04/2015
3LigandsIBA
10/2021 - 12/2014
3B7-H1 AntigenIBA
01/2021 - 04/2018
3lenvatinibIBA
01/2021 - 04/2018
3Axitinib (AG 013736)IBA
10/2019 - 01/2014
3Monoclonal AntibodiesIBA
01/2018 - 07/2013
3CarcinogensIBA
04/2006 - 01/2002
2CytokinesIBA
11/2023 - 12/2016
2Interleukin-6 (Interleukin 6)IBA
11/2023 - 12/2016
2milbemycin oxime (Interceptor)IBA
10/2023 - 01/2020
2durvalumabIBA
01/2023 - 10/2017
2Anti-Bacterial Agents (Antibiotics)IBA
11/2021 - 01/2016
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 07/2008
2Long Noncoding RNAIBA
01/2020 - 01/2017
2Proteins (Proteins, Gene)FDA Link
01/2020 - 04/2013
2AfatinibIBA
10/2019 - 01/2018
2avelumabIBA
08/2018 - 10/2017
2Phosphotransferases (Kinase)IBA
04/2018 - 04/2015
2NVP-BKM120IBA
01/2018 - 01/2017
2Panitumumab (Vectibix)FDA Link
01/2018 - 07/2013
2fosbretabulin (combretastatin A4)IBA
10/2014 - 02/2014
2Tyrosine Kinase InhibitorsIBA
12/2013 - 10/2013
2Gefitinib (Iressa)FDA Link
11/2012 - 04/2009
2Cyclin-Dependent Kinase Inhibitor p16IBA
10/2006 - 06/2003
1Tramadol (K315)FDA LinkGeneric
01/2024
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2023
1ChemokinesIBA
11/2023
1Estrogens (Estrogen)FDA Link
04/2023

Therapy/Procedure

56Therapeutics
03/2024 - 06/2006
52Drug Therapy (Chemotherapy)
12/2022 - 07/2002
35Radiotherapy
11/2023 - 08/2002
12Immunotherapy
01/2024 - 01/2016
11Chemoradiotherapy
03/2024 - 11/2009
9Induction Chemotherapy
10/2023 - 02/2014
7Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
02/2020 - 05/2004
4Heavy Ion Radiotherapy
10/2023 - 11/2021
3Aftercare (After-Treatment)
01/2021 - 12/2016
2Time-to-Treatment
05/2021 - 01/2016
2Metastasectomy
01/2017 - 10/2005